Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Esperion Therapeutics shares rose by 7.1% in pre-market trading after presenting new data from CLEAR outcomes at ACC.24, highlighting the value of NEXLETOL tablets. Other stocks also showed significant movement in pre-market trading, with Longeveron Inc. leading the gainers and 22nd Century Group, Inc. leading the losers.
April 08, 2024 | 9:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Esperion Therapeutics shares rose by 7.1% in pre-market trading after presenting new data on NEXLETOL tablets.
The positive data presentation on NEXLETOL tablets is likely to boost investor confidence in Esperion Therapeutics, leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Longeveron Inc. shares rose by 93.2% in pre-market trading after an 8% gain on Friday.
The significant pre-market increase for Longeveron Inc. follows a previous gain, indicating strong investor interest and potential for continued short-term growth.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 80
NEGATIVE IMPACT
22nd Century Group, Inc. shares declined by 22.4% in pre-market trading after a 140% jump on Friday due to a new contract manufacturing agreement.
The sharp decline in 22nd Century Group's shares could be a market correction following Friday's significant surge, indicating a potential short-term decrease in stock price.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 80